News
Newly-promoted Bundesliga side Hamburger SV have strengthened their defense ahead of the 2025/26 season.On Thursday, the ...
Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.
Giorgi Gocholeishvili is already the ninth HSV newcomer of the summer. The Georgian could become a regular player almost ...
HSV's new signing Yussuf Poulsen is currently training only in a limited capacity. The striker, who has recently been plagued ...
Assembly Biosciences ( NASDAQ: ASMB) reported promising results from an early stage study of its experimental candidate, ...
The 23-year-old had already decided to join Nice and completed a medical with the French club, but the deal collapsed unexpectedly. Speaking during HSV’s training camp in Mallorca, Königsdörffer ...
Growing research shows common herpes viruses may raise dementia risk, challenging previous skepticism and opening new paths ...
When former Spice Girl Mel B revealed that she was temporarily blinded in one eye due to a herpes-related complication, it ...
Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment ...
HSV-2 infection and syphilis are two of the main causes of genital ulceration 1–3 and have been associated with an increased risk of human immunodeficiency virus (HIV) infection in observational ...
The HSV-2–seropositive partners were randomly assigned, in a 1:1 ratio, to 500 mg of valacyclovir once daily or to matching placebo. 23 At each visit, safer sex practices, including the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results